Ad
related to: eli lilly and company stock price
Search results
Biotech Behemoths: 3 Giants Set to Dominate the Health Scene
InvestorPlace· 1 day agoBiotechnology is an interesting place to look if you’re looking for growth and are not put off by...
Fighting Obesity Using ETFs | ETF Trends
ETF Trends· 2 days agoWeight loss has long been a challenge for many people, me included. Indeed, there are an estimated 1 billion individuals living with obesity, and the...
Earnings-Proof Tech Plays: 3 Stocks Set to Stay Hot Beyond Reporting Season
InvestorPlace· 5 days agoDepending on where you look, there has been quite a tough crowd of investors to please this earnings...
PRIMECAP Management's Strategic Exits and Acquisitions in Q1 202
Guru Focus· 24 hours agoInsightful Analysis of PRIMECAP's Latest 13F Filing Founded in 1983, PRIMECAP Management (Trades, Portfolio) is a distinguished investment management firm base
Damien Conover and Rebecca Springer: ‘We Are in a Healthcare Consumerization Moment Right Now’
Morningstar· 17 hours agoDamien is director of healthcare research and director of equity strategy for Morningstar Research...
Short-Term Market Volatility Could Provide Long-Term Investing Opportunities
Morningstar· 5 days agoWhy Morningstar thinks Apple could turn it around for 2025. Plus, the Federal Reserve is delaying...
Five S&P 500 Stocks To Watch In Today's Market; Amazon Stock Hits New High
Investor's Business Daily· 5 days agoThe stock gapped up 6% in heavy volume after the drugmaker reported higher-than-expected adjusted...
3 ETFs That Are Screaming Buys in May | The Motley Fool
The Motley Fool· 3 days agoEach has a different focus that complements the others well. One ETF that I'll almost always...
S&P 500 (SPX) today: Bath & Body Works, Inc. is a top mover, up 3.01%
USA Today· 21 hours agoThe S&P 500 opened today at 5,221.10. Within 30 minutes of trading, the benchmark index rose by 3.09...
Earnings call: Nektar Therapeutics optimistic on REZPEG and pipeline progress By Investing.com
Investing.com· 5 days agoThe company is advancing its pipeline, including the TNFR2 agonist antibody NKTR-0165 for various...